These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26553068)

  • 1. Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions.
    Lee JG; Shin JH; Shim HS; Lee CY; Kim DJ; Kim YS; Chung KY
    Respir Res; 2015 Nov; 16():138. PubMed ID: 26553068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of autophagy promotes cisplatin-induced apoptotic cell death through Atg5 and Beclin 1 in A549 human lung cancer cells.
    Chen J; Zhang L; Zhou H; Wang W; Luo Y; Yang H; Yi H
    Mol Med Rep; 2018 May; 17(5):6859-6865. PubMed ID: 29512762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells.
    Cimas FJ; Callejas-Valera JL; Pascual-Serra R; García-Cano J; Garcia-Gil E; De la Cruz-Morcillo MA; Ortega-Muelas M; Serrano-Oviedo L; Gutkind JS; Sánchez-Prieto R
    Oncotarget; 2015 Dec; 6(42):44095-107. PubMed ID: 26689986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma.
    Hao C; Liu G; Tian G
    Ther Adv Respir Dis; 2019; 13():1753466619866097. PubMed ID: 31368411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP.
    Wang BS; Liu YZ; Yang Y; Zhang Y; Hao JJ; Yang H; Wang XM; Zhang ZQ; Zhan QM; Wang MR
    Clin Sci (Lond); 2013 Feb; 124(3):203-14. PubMed ID: 22963397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy.
    Ren JH; He WS; Nong L; Zhu QY; Hu K; Zhang RG; Huang LL; Zhu F; Wu G
    Cancer Biother Radiopharm; 2010 Feb; 25(1):75-80. PubMed ID: 20187799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
    Wang M; Li G; Yang Z; Wang L; Zhang L; Wang T; Zhang Y; Zhang S; Han Y; Jia L
    Oncotarget; 2017 Jan; 8(5):8083-8094. PubMed ID: 28042952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bu-Zhong-Yi-Qi Decoction, the Water Extract of Chinese Traditional Herbal Medicine, Enhances Cisplatin Cytotoxicity in A549/DDP Cells through Induction of Apoptosis and Autophagy.
    Yu N; Xiong Y; Wang C
    Biomed Res Int; 2017; 2017():3692797. PubMed ID: 28154825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-induced downregulation of SOX1 increases drug resistance by activating autophagy in non-small cell lung cancer cell.
    Li N; Li X; Li S; Zhou S; Zhou Q
    Biochem Biophys Res Commun; 2013 Sep; 439(2):187-90. PubMed ID: 23994634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells.
    Wu HM; Jiang ZF; Ding PS; Shao LJ; Liu RY
    Sci Rep; 2015 Jul; 5():12291. PubMed ID: 26201611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese herbal medicine Feiyanning cooperates with cisplatin to enhance cytotoxicity to non-small-cell lung cancer by inhibiting protective autophagy.
    Zheng Z; Ma Y; Wang L; Deng H; Wang Z; Li J; Xu Z
    J Ethnopharmacol; 2021 Aug; 276():114196. PubMed ID: 33984457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells.
    Pradhan S; Mahajan D; Kaur P; Pandey N; Sharma C; Srivastava T
    Oncotarget; 2016 Nov; 7(44):71841-71855. PubMed ID: 27708247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin.
    Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S
    Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
    Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
    Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089.
    Sharma K; Goehe RW; Di X; Hicks MA; Torti SV; Torti FM; Harada H; Gewirtz DA
    Autophagy; 2014; 10(12):2346-61. PubMed ID: 25629933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nonprotective autophagy and the autophagic switch on sensitivity to cisplatin in non-small cell lung cancer cells.
    Patel NH; Xu J; Saleh T; Wu Y; Lima S; Gewirtz DA
    Biochem Pharmacol; 2020 May; 175():113896. PubMed ID: 32135156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance.
    García-Cano J; Ambroise G; Pascual-Serra R; Carrión MC; Serrano-Oviedo L; Ortega-Muelas M; Cimas FJ; Sabater S; Ruiz-Hidalgo MJ; Sanchez Perez I; Mas A; Jalón FA; Vazquez A; Sánchez-Prieto R
    Oncotarget; 2015 Jun; 6(17):15551-65. PubMed ID: 26036632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
    Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP
    Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.